Phentermine Hydrochloride
Generic: Phentermine Hydrochloride
Labeler: TAGI Pharma, IncDrug Facts
Product Profile
Brand Name
Phentermine Hydrochloride
Generic Name
Phentermine Hydrochloride
Labeler
TAGI Pharma, Inc
Dosage Form
CAPSULE
Routes
Active Ingredients
PHENTERMINE HYDROCHLORIDE 15 mg/1
Identifiers & Regulatory
Product NDC
51224-203
Product ID
51224-203_daad17fe-5fa7-4595-aff9-50b141a6aa31
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202248
DEA Schedule
CIV
Marketing Start
2012-02-17
Marketing End
2026-02-28
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51224203
Hyphenated Format
51224-203
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
Phentermine Hydrochloride (source: ndc)
Generic Name
Phentermine Hydrochloride (source: ndc)
Application Number
ANDA202248 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 15 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (51224-203-50)
- 1000 CAPSULE in 1 BOTTLE (51224-203-70)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "daad17fe-5fa7-4595-aff9-50b141a6aa31", "openfda": {"upc": ["0351224203709", "0351224203501", "0351224202504", "0351224202702"], "unii": ["0K2I505OTV"], "rxcui": ["900038", "968766"], "spl_set_id": ["2acb0c69-0089-4817-86ad-6df592c0356e"], "manufacturer_name": ["TAGI Pharma, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (51224-203-50)", "package_ndc": "51224-203-50", "marketing_end_date": "20260228", "marketing_start_date": "20120217"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (51224-203-70)", "package_ndc": "51224-203-70", "marketing_end_date": "20260228", "marketing_start_date": "20120217"}], "brand_name": "Phentermine Hydrochloride", "product_id": "51224-203_daad17fe-5fa7-4595-aff9-50b141a6aa31", "dosage_form": "CAPSULE", "pharm_class": ["Appetite Suppression [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "51224-203", "dea_schedule": "CIV", "generic_name": "Phentermine Hydrochloride", "labeler_name": "TAGI Pharma, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phentermine Hydrochloride", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA202248", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20120217"}